Published by Iain Gilbert on 22nd September 2026
(Sharecast News) - Biotechnology firm Oxford Biomedica said on Tuesday that strong commercial momentum and expanding manufacturing capacity continued to underpin its long‑term growth outlook, as the group reiterated full‑year guidance alongside a solid first‑half performance.
URL: http://www.digitallook.com/dl/news/story/36226356/...